Protein Science, Vol 3, Issue 8 1267-1275, Copyright © 1994 by Cold Spring Harbor Laboratory Press

ARTICLE

Two-step selective formation of three disulfide bridges in the synthesis of the C-terminal epidermal growth factor-like domain in human blood coagulation factor IX

Y. YANG, W. V. SWEENEY, K. SCHNEIDER, B. T. CHAIT and J. P. TAM
Department of Chemistry, Hunter College of City University of New York, New York, New York 10021

The 45-residue C-terminal EGF-like domain in human blood coagulation factor IX has been synthesized by a 2-step method to form selectively 3 disulfide bridges. Four out of 6 cysteines are blocked with either trityl or 4-methyl-benzyl, and the remaining 2 cysteines are blocked with acetamidomethyl (Acm). In the first step, 4 free cysteinyl thiols are released concurrently with the removal of all protecting groups except Acm and are oxidized to form 1 of the 3 possible isomers containing 2 pairs of disulfides. In the second step, iodine is used to remove the Acm groups to yield the third disulfide bridge. This approach reduces the number of possible disulfide bridging patterns from 15 to 3. To determine the optimal protecting group strategy, 3 peptides are synthesized, each with Acm blocking 1 of the 3 pairs of cysteines involved in disulfide bridges: Cys(5) to Cys(16) (Cys 1-3), Cys(12) to Cys(26) (Cys 2-4), or Cys(28) to Cys(41) (Cys 5-6). Only the peptide having the Cys 2-4 pair blocked with Acm forms the desired disulfide isomer (Cys 1-3/5-6) in high yield after the first step folding, as identified by proteolytic digestion in conjunction with mass spectrometric peptide mapping. Thus, the choice of which pair of cysteines to block with Acm is critically important. In the case of EGF-like peptides, it is better to place the Acm blocking groups on one of the pairs of cysteines involved in the crossing of disulfide bonds.
CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Tolkatchev, S. Malik, A. Vinogradova, P. Wang, Z. Chen, P. Xu, H. P.J. Bennett, A. Bateman, and F. Ni Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities Protein Sci., April 1, 2008; 17(4): 711 - 724. [Abstract] [Full Text] [PDF]

				J. P. Tam, Y.-A. Lu, and J.-L. Yang Correlations of Cationic Charges with Salt Sensitivity and Microbial Specificity of Cystine-stabilized beta -Strand Antimicrobial Peptides J. Biol. Chem., December 20, 2002; 277(52): 50450 - 50456. [Abstract] [Full Text] [PDF]

				Q. Yu, R. I. Lehrer, and J. P. Tam Engineered Salt-insensitive alpha -Defensins with End-to-end Circularized Structures J. Biol. Chem., February 11, 2000; 275(6): 3943 - 3949. [Abstract] [Full Text] [PDF]

				J. P. Tam, Y.-A. Lu, J.-L. Yang, and K.-W. Chiu An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides PNAS, August 3, 1999; 96(16): 8913 - 8918. [Abstract] [Full Text] [PDF]

				F. H. Wilkinson, S. S. Ahmad, and P. N. Walsh The Factor IXa Second Epidermal Growth Factor (EGF2) Domain Mediates Platelet Binding and Assembly of the Factor X Activating Complex J. Biol. Chem., February 15, 2002; 277(8): 5734 - 5741. [Abstract] [Full Text] [PDF]

				T. M. Hackeng, J. A. Fernandez, P. E. Dawson, S. B. H. Kent, and J. H. Griffin Chemical synthesis and spontaneous folding of a multidomain protein: Anticoagulant microprotein S PNAS, December 19, 2000; 97(26): 14074 - 14078. [Abstract] [Full Text] [PDF]